Thalidomide to Patients With Previously Untreated Multiple Myeloma
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effect of thalidomide in patients with multiple
myeloma. The patients receive either thalidomide or a placebo tablet (neither patient nor
doctor know which of these are given) in addition to the ordinary chemotherapeutic drug
against multiple myeloma. We will find out for how long time the patients will stay free of
the disease and for how long time they will live, and can evaluate whether thalidomide is a
beneficial drug against this disease.
Phase:
Phase 3
Details
Lead Sponsor:
Norwegian University of Science and Technology
Collaborators:
Nordic Myeloma Study Group, Germany The Research Council of Norway